Playback speed
10 seconds
ESMO 2022 on the NICHE-2 Study: Neoadjuvant Immune Checkpoint Inhibition in Locally Advanced dMMR Colon Cancer
By
ESMO 2022 Conference Coverage
FEATURING
Myriam Chalabi
By
ESMO 2022 Conference Coverage
FEATURING
Myriam Chalabi
900 views
September 16, 2022
Login to view comments.
Click here to Login